Startups
AudioCure Pharma specializes in the preclinical and clinical development of small molecules for the treatment of audiological and neurodegenerative diseases like sudden hearing loss, tinnitus, Parkinson’s and Alzheimer’s disease. In a first step the company focuses on sudden hearing loss.
Our compounds AC102 and AC002 have shown excellent efficacy in different animal models for the above-mentioned indications. Consequently, AudioCure is on its way to perform formal preclinical tests and to move AC102 into first-in-man testing.
Our compounds AC102 and AC002 have shown excellent efficacy in different animal models for the above-mentioned indications. Consequently, AudioCure is on its way to perform formal preclinical tests and to move AC102 into first-in-man testing.
Overview
Location
Germany, Berlin
Employees
51-200
Total raised
$10.25M
Founded date
2010
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 29, 2012 | AudioCure Pharma Raises Seed Funding | AudioCure Pharma GmbH, a Berlin, Germany-based start up focused on the clinical development of drug candidates in neurodegenerative disease indications, has raised a seed financing of undisclosed amount. Backers include High-Tech Gründerfon... |
| AudioCure Pharma GmbH secures funding of about EUR 9 million for the further development of their lead candidate, AC102, in hearing loss | AudioCure, a pharmaceutical R&D company headquartered in Germany, announces today that it has secured an A-round of about EUR 9 million from MED-EL, HTGF and private investors. MED-EL receives exclusive licensing rights and shares while... |
Reviews 0
FAQ about AudioCure
When was AudioCure founded?
AudioCure was founded in 2010.
How much funding has AudioCure raised?
AudioCure has raised $10.25M in total across 1 funding round.
What has the press written about AudioCure?
Parsers VC has collected 3 articles mentioning AudioCure, among them “AudioCure Pharma Raises Seed Funding” (May 29, 2012) and “AudioCure Pharma GmbH secures funding of about EUR 9 million for the further development of their lead candidate, AC102, in hearing loss”.
Is AudioCure still active?
AudioCure is probably closed: its latest activity on Parsers VC dates from Nov 29, 2016.